LEADER 05168nam 22006254a 450 001 9910145833303321 005 20210201231407.0 010 $a1-282-01315-7 010 $a9786612013157 010 $a1-4443-0022-9 010 $a1-4443-0023-7 035 $a(CKB)1000000000715940 035 $a(EBL)416389 035 $a(OCoLC)437096889 035 $a(SSID)ssj0000123533 035 $a(PQKBManifestationID)11134810 035 $a(PQKBTitleCode)TC0000123533 035 $a(PQKBWorkID)10009041 035 $a(PQKB)10090757 035 $a(MiAaPQ)EBC416389 035 $a(PPN)152250859 035 $a(EXLCZ)991000000000715940 100 $a20070718d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aClinical endocrine oncology$b[electronic resource] /$fedited by Ian D. Hay, John A.H. Wass ; foreword by Anthony P. Weetman 205 $a2nd ed. 210 $aMalden, Mass. $cBlackwell Pub.$d2008 215 $a1 online resource (680 p.) 300 $aDescription based upon print version of record. 311 $a1-4051-4584-6 320 $aIncludes bibliographical references and index. 327 $aList of Contributors; Foreword; Preface; 1 Endocrine Oncology and Therapeutic Options; 1 Structure and Development of the Endocrine System; 2 Epidemiology of Endocrine Tumors; 3 Inherited Cancers, Genes, and Chromosomes; 4 Hormones, Growth Factors, and Tumor Growth; 5 Genetic Counseling and Clinical Cancer Genetics; 6 Prospects for Gene Therapy for Endocrine Malignancies; 7 Tumor Targeting; 8 Techniques in Radiation Medicine; 9 Interventional Radiology; 10 Surgical Management of Endocrine Tumors; 11 Endocrine Tumor Markers; 12 General Management of Cancer Patients 327 $a2 Thyroid and Parathyroid Tumors13 Assessment of Thyroid Neoplasia; 14 Thyroid and Parathyroid Imaging; 15 Pathogenesis of Thyroid Cancer; 16 Papillary Thyroid Carcinoma; 17 Follicular Thyroid Carcinoma; 18 Anaplastic Thyroid Carcinoma; 19 Thyroid Lymphoma; 20 Radiation-induced Thyroid Tumors; 21 Parathyroid Adenomas and Hyperplasia; 22 Parathyroid Carcinoma; 3 Pituitary and Hypothalamic Lesions; 23 Molecular Pathogenesis of Pituitary Adenomas; 24 Functional Assessment of the Pituitary; 25 Imaging of the Pituitary and Hypothalamus; 26 Pathology of Tumors of the Pituitary 327 $a27 Surgery for Pituitary Tumors 28 Pituitary Radiotherapy; 29 Prolactinomas; 30 Acromegaly; 31 Cushing's Disease; 32 Non-functioning Pituitary Adenomas andGonadotropinomas; 33 Thyrotropinomas; 34 Pituitary Carcinoma; 35 Pituitary Incidentalomas; 36 Craniopharyngioma; 37 Benign Cysts: Rathke's Cleft Cysts,Mucoceles, Arachnoid Cysts, and Dermoid and Epidermoid Cysts; 38 Hypothalamic Hamartomas and Gangliocytomas; 39 Cranial Ependymoma; 40 Perisellar Tumors including Chordoma,Optic Nerve Glioma, Meningioma,Hemangiopericytoma, and Glomus Tumors 327 $a41 Pineal Tumors: Germinomas andNon-germinomatous Germ Cell Tumors 42 Cavernous Sinus Hemangiomas; 43 Langerhans' Cell Histiocytosis; 44 Pituitary and Hypothalamic Sarcoidosis; 4 Adrenal and Gonadal Tumors; 45 Imaging of the Adrenal Glands; 46 Pheochromocytoma; 47 Peripheral Neuroblastic Tumors; 48 Primary Hyperaldosteronism; 49 Adrenal Causes of Cushing's Syndrome; 50 Adrenal Incidentalomas; 51 Androgen-secreting Tumors; 52 Functional Ovarian Tumors; 53 Endocrine Aspects of Ovarian Tumors; 54 Testicular Germ Cell Cancers; 55 Neoplasia and Intersex States 327 $a56 Gestational Trophoblastic Neoplasia 5 Neuroendocrine Tumors and the Clinical Syndromes; 57 Classification of Neuroendocrine Tumors; 58 Imaging of GastrointestinalNeuroendocrine Tumors; 59 Insulinomas and Hypoglycemia; 60 Gastrinomas (Zollinger-Ellison Syndrome); 61 VIPomas; 62 Glucagonomas; 63 Somatostatinomas; 64 Lung and Thymic Neuroendocrine Tumors; 65 Carcinoid Syndrome; 66 Appendiceal and Hindgut Carcinoids; 67 Chemotherapy for Neuroendocrine Tumors; 6 Medical Syndromes andEndocrine Neoplasia; 68 Multiple Endocrine Neoplasia Type 1 (MEN 1) 327 $a69 Medullary Thyroid Carcinoma and AssociatedMultiple Endocrine Neoplasia Type 2 330 $aA truly comprehensive reference for the management of patients with endocrine cancer The new edition of Clinical Endocrine Oncology has been fully revised and extended making it the most comprehensive and up-to-date reference available. Written and edited by leading international experts in the field, it sets the standard in multidisciplinary care for patients with endocrine tumors. The book provides specific and detailed guidance on the basic, clinical, investigative and therapeutic processes required for the thorough evaluation of a patient with a tumor in an endoc 606 $aEndocrine glands$xTumors 615 0$aEndocrine glands$xTumors. 676 $a616.99/44 676 $a616.9944 701 $aHay$b Ian D$0970571 701 $aWass$b J. A. H$0970572 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910145833303321 996 $aClinical endocrine oncology$92206003 997 $aUNINA LEADER 03425nam 22005415 450 001 9910686793103321 005 20251008140653.0 010 $a9783031234095$b(electronic bk.) 010 $z9783031234088 024 7 $a10.1007/978-3-031-23409-5 035 $a(MiAaPQ)EBC7233690 035 $a(Au-PeEL)EBL7233690 035 $a(DE-He213)978-3-031-23409-5 035 $a(OCoLC)1377823447 035 $a(PPN)269659900 035 $a(CKB)26428577800041 035 $a(EXLCZ)9926428577800041 100 $a20230403d2023 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aB2B Customer Engagement Strategy $eAn Introduction to Managing Customer Experience /$fby Daniel D. Prior 205 $a1st ed. 2023. 210 1$aCham :$cSpringer International Publishing :$cImprint: Palgrave Macmillan,$d2023. 215 $a1 online resource (233 pages) 311 08$aPrint version: Prior, Daniel D. B2B Customer Engagement Strategy Cham : Springer International Publishing AG,c2023 9783031234088 320 $aIncludes bibliographical references and index. 327 $a1. What is Customer Engagement ? -- 2. CE Context -- 3. Customer Experience (CX) and Customer Journey -- 4. The Case for CE Capability -- 5. Customer Journey Management -- 6. Customer Relationship Management (CRM) -- 7. Customer Communications -- 8. Analytics and Insight -- 9. CE Capability Maturity -- 10. Current Issues in CE. . 330 $aBusiness to business (B2B) transactions account for 60-70% of all transactions globally. Considering this, many supplier firms aspire to create high levels of customer engagement, and this involves identifying various ways to improve customer experience. In fact, companies such as Google, Amazon, Microsoft, and others now employ professionals in customer engagement roles and dedicate entire corporate divisions to ensure seamless customer engagement. Creating high customer engagement is challenging without a cohesive, strategic approach ? particularly in B2B markets. This textbook introduces students to customer engagement strategy in B2B markets, the foundation of which is customer engagement capability. Companies must develop and implement four sub-capabilities ? customer journey management, customer relationship management, customer communications and data analytics and insight to succeed. With a myriad of case studies, discussion questions and prompts forfurther reading, the textbook translates theory into practice and serves as a useful foundation for executive courses as well as fundamental reading for masters-level specialist courses in customer engagement, marketing, sales, and strategy. In addition, practitioners in supplier firms will also be able to use to build their customer engagement capability. . 606 $aCustomer relations$xManagement 606 $aMarketing 606 $aCustomer Relationship Management 606 $aMarketing 615 0$aCustomer relations$xManagement. 615 0$aMarketing. 615 14$aCustomer Relationship Management. 615 24$aMarketing. 676 $a658.812 676 $a658.804 700 $aPrior$b Daniel D.$0851607 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 912 $a9910686793103321 996 $aB2B Customer Engagement Strategy$93087640 997 $aUNINA